10x Genomics, Inc. (TXG)
Sector: Technology
Industry: Laboratory Analytical Instruments
Country: United States
Exchange: NASDAQ
Market cap: $9.98B
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
Latest financial period: June 30, 2026
Filed with the SEC: August 7, 2026
Estimated earnings date: November 5, 2026
Profit #1273 of 1484 companies
| | Jun 26 | Mar 26 | Dec 25 | Sep 25 |
|---|
| ROE/ROA | 11.4% | 12.2% | 11.2% | 10.2% |
Growth #950 of 1484 companies
Payout #1117 of 1484 companies
Safety #310 of 1484 companies
Price #1297 of 1484 companies
